Home   Search   Browse   Statistics   User guide   FAQs   Post question   Download   Process data  
Search results for the GEO ID: GSE40837
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM1003005
GPL570
Human breast tumor pre treatment, biological rep1 Human breast tumor, pre sorafenib treatment tissue: breast tumor age: 44 er status: Positive pgr status: Positive endocrine agent: Tamoxifen status on endocrine agent: Progressive disease (PD) response to sorafenib: N/A Gene expression data from human breast cancer
GSM1003006
GPL570
Human breast tumor post treatment, biological rep1 Human breast tumor, post sorafenib treatment tissue: breast tumor age: 44 er status: Positive pgr status: Positive endocrine agent: Tamoxifen status on endocrine agent: N/A response to sorafenib: Stable disease (SD) Gene expression data from human breast cancer
GSM1003007
GPL570
Human breast tumor pre treatment, biological rep2 Human breast tumor, pre sorafenib treatment tissue: breast tumor age: 41 er status: Positive pgr status: Positive endocrine agent: Tamoxifen status on endocrine agent: Stable disease (SD) response to sorafenib: N/A Gene expression data from human breast cancer
GSM1003008
GPL570
Human breast tumor post treatment, biological rep2 Human breast tumor, post sorafenib treatment tissue: breast tumor age: 41 er status: Positive pgr status: Positive endocrine agent: Tamoxifen status on endocrine agent: N/A response to sorafenib: Stable disease (SD) Gene expression data from human breast cancer
GSM1003009
GPL570
Human breast tumor pre treatment, biological rep3 Human breast tumor, pre sorafenib treatment tissue: breast tumor age: 45 er status: Positive pgr status: Positive endocrine agent: Tamoxifen status on endocrine agent: Progressive disease (PD) response to sorafenib: N/A Gene expression data from human breast cancer
GSM1003010
GPL570
Human breast tumor post treatment, biological rep3 Human breast tumor, post sorafenib treatment tissue: breast tumor age: 45 er status: Positive pgr status: Positive endocrine agent: Tamoxifen status on endocrine agent: N/A response to sorafenib: Progressive disease (PD) Gene expression data from human breast cancer
GSM1003011
GPL570
Human breast tumor pre treatment, biological rep4 Human breast tumor, pre sorafenib treatment tissue: breast tumor age: 63 er status: Positive pgr status: Negative endocrine agent: Letrozole status on endocrine agent: Progressive disease (PD) response to sorafenib: N/A Gene expression data from human breast cancer
GSM1003012
GPL570
Human breast tumor post treatment, biological rep4 Human breast tumor, post sorafenib treatment tissue: breast tumor age: 63 er status: Positive pgr status: Negative endocrine agent: Letrozole status on endocrine agent: N/A response to sorafenib: Stable disease (SD) Gene expression data from human breast cancer
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes